These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15207541)

  • 21. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
    Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
    Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cosmetic features and applications of lipid nanoparticles (SLN, NLC).
    Souto EB; Müller RH
    Int J Cosmet Sci; 2008 Jun; 30(3):157-65. PubMed ID: 18452432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid lipid nanoparticles (SLN)--based hydrogels as potential carriers for oral transmucosal delivery of risperidone: preparation and characterization studies.
    Silva AC; Amaral MH; González-Mira E; Santos D; Ferreira D
    Colloids Surf B Biointerfaces; 2012 May; 93():241-8. PubMed ID: 22293602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
    Pardeike J; Hommoss A; Müller RH
    Int J Pharm; 2009 Jan; 366(1-2):170-84. PubMed ID: 18992314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
    Severino P; Santana MH; Souto EB
    Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.
    Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV
    Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
    Teeranachaideekul V; Müller RH; Junyaprasert VB
    Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
    Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
    Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrophilic coating of mitotane-loaded lipid nanoparticles: preliminary studies for mucosal adhesion.
    Severino P; Souto EB; Pinho SC; Santana MH
    Pharm Dev Technol; 2013; 18(3):577-81. PubMed ID: 21958059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
    Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E
    J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of solid lipid nanoparticles using a membrane contactor.
    Charcosset C; El-Harati A; Fessi H
    J Control Release; 2005 Nov; 108(1):112-20. PubMed ID: 16169111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
    Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
    Cirri M; Bragagni M; Mennini N; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.